What Is GLP-1 Semaglutide?
Semaglutide is a GLP-1 receptor agonist that mimics a natural hormone your body produces after eating. It has been clinically studied for chronic weight management and may help patients achieve meaningful weight loss when combined with diet and exercise.
Clinical studies have shown that Semaglutide may help patients achieve notable weight loss, making it one of the most studied non-surgical weight management interventions available. Individual results vary.
How It Works
Semaglutide activates GLP-1 receptors in the brain and gut, creating a powerful appetite-reducing effect while simultaneously improving how your body processes food and regulates blood sugar.
- Signals the brain’s appetite center to reduce hunger and food cravings
- Slows gastric emptying so you feel satisfied with smaller portions
- Improves insulin sensitivity and helps stabilize blood sugar levels
- Reduces visceral fat, the dangerous fat around internal organs
- May lower cardiovascular risk factors including blood pressure
What to Expect
You’ll start on a low dose that increases gradually over 16–20 weeks, allowing your body to adjust and minimizing potential side effects like nausea. Most patients notice reduced appetite within the first week or two.
The medication is administered as a once-weekly subcutaneous injection. Your physician monitors progress through regular check-ins, adjusting dosage and providing nutritional guidance to maximize results.
Who Is It For?
Semaglutide is typically prescribed for adults with a BMI of 30+, or 27+ with weight-related health considerations. It may be suitable for patients who want a physician-supervised, science-backed approach to weight management. Your doctor will determine if it’s right for you.